相似文献
1
Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.
Biochem J. 1999 Jun 1;340 ( Pt 2)(Pt 2):393-6.
2
Leishmanicidal activity of stearylamine-bearing liposomes in vitro.
J Parasitol. 2001 Feb;87(1):188-93. doi: 10.1645/0022-3395(2001)087[0188:LAOSBL]2.0.CO;2.
3
Biological effects and cellular uptake of c-myc antisense oligonucleotides and their cationic liposome complexes.
J Drug Target. 1998;5(4):235-46. doi: 10.3109/10611869808995878.
4
The effect of beta-tubulin-specific antisense oligonucleotide encapsulated in different cationic liposomes on the suppression [correction of supression] of intracellular L. donovani parasites in vitro.
J Biochem. 2002 Jul;132(1):23-7. doi: 10.1093/oxfordjournals.jbchem.a003194.
5
Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine.
J Antimicrob Chemother. 2008 Jan;61(1):103-10. doi: 10.1093/jac/dkm396. Epub 2007 Oct 26.
6
Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
J Natl Cancer Inst. 2004 Aug 4;96(15):1171-80. doi: 10.1093/jnci/djh221.
7
Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
Exp Parasitol. 2000 Mar;94(3):150-7. doi: 10.1006/expr.1999.4486.
8
Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus.
Biochem Biophys Res Commun. 2000 Dec 9;279(1):158-61. doi: 10.1006/bbrc.2000.3924.
9
Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.
Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7859-63. doi: 10.1073/pnas.91.17.7859.
10
A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
Vaccine. 2004 Mar 12;22(9-10):1162-71. doi: 10.1016/j.vaccine.2003.09.030.
引用本文的文献
1
Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro.
J Nanobiotechnology. 2019 Apr 22;17(1):57. doi: 10.1186/s12951-019-0490-2.
2
Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct.
Iran J Parasitol. 2013 Apr;8(2):190-6.
3
Knockdown of LdMC1 and Hsp70 by antisense oligonucleotides causes cell-cycle defects and programmed cell death in Leishmania donovani.
Mol Cell Biochem. 2012 Jan;359(1-2):135-49. doi: 10.1007/s11010-011-1007-y. Epub 2011 Jul 31.
4
Design and evaluation of liposomal formulation of pilocarpine nitrate.
Indian J Pharm Sci. 2010 Mar;72(2):155-60. doi: 10.4103/0250-474X.65014.
5
Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.
Parasitol Res. 2003 Jun;90 Suppl 2:S63-70. doi: 10.1007/s00436-002-0769-2. Epub 2002 Dec 11.
6
Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.
Biochem Pharmacol. 2001 Sep 1;62(5):569-80. doi: 10.1016/s0006-2952(01)00695-5.
7
Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides.
Pharm Res. 2000 Jun;17(6):707-14. doi: 10.1023/a:1007582332491.
本文引用的文献
1
Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in culture.
J Drug Target. 1998;5(3):149-62. doi: 10.3109/10611869808995870.
2
A novel peptide-grafted liposomal delivery system targeted to macrophages.
Antimicrob Agents Chemother. 1998 Feb;42(2):348-51. doi: 10.1128/AAC.42.2.348.
3
Leishmania phagolysosome: drug trafficking and protein sorting across the compartment.
Crit Rev Microbiol. 1997;23(3):253-68. doi: 10.3109/10408419709115139.
4
Antisense inhibition of angiotensinogen in hepatoma cell culture is enhanced by cationic liposome delivery.
Biochem Biophys Res Commun. 1997 Mar 27;232(3):794-9. doi: 10.1006/bbrc.1997.6329.
5
Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotide to Leishmania-infected macrophages. Selective and efficient elimination of the parasite.
Biochem Pharmacol. 1997 Feb 7;53(3):385-91. doi: 10.1016/s0006-2952(96)00763-0.
6
Mechanism of oligonucleotide release from cationic liposomes.
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11493-8. doi: 10.1073/pnas.93.21.11493.
7
Drug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomes.
J Antimicrob Chemother. 1996 Jul;38(1):145-50. doi: 10.1093/jac/38.1.145.
8
Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates.
Pharm Res. 1995 Oct;12(10):1548-53. doi: 10.1023/a:1016260110049.
9
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
Science. 1993 Aug 20;261(5124):1004-12. doi: 10.1126/science.8351515.
10
Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.
Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7859-63. doi: 10.1073/pnas.91.17.7859.
Zotero 插件